| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/22/2004 | WO2004060350A1 Immobilisation of dna-labelled lipid vesicles on dna arrays |
| 07/22/2004 | WO2004060304A2 Novel compositions and methods in cancer |
| 07/22/2004 | WO2004060302A2 Methods and compositions for the diagnosis, prognosis, and treatment of cancer |
| 07/22/2004 | WO2004060301A2 Novel compositions and methods in cancer |
| 07/22/2004 | WO2004060295A2 Methods of inducing and maintaining immune tolerance |
| 07/22/2004 | WO2004060294A2 Functionalization of immobilized proteins |
| 07/22/2004 | WO2004060293A2 Methods and compositions for protection against thrombolysis-associated reperfusion injury |
| 07/22/2004 | WO2004060282A2 Uses of the snorf207 receptor |
| 07/22/2004 | WO2004060280A2 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 07/22/2004 | WO2004060262A2 Modulators of notch signalling for use in immunotherpapy |
| 07/22/2004 | WO2004060145A2 Isolation and identification of cross-reactive t cells |
| 07/22/2004 | WO2004060053A2 Transgenic mice expressing human cd20 |
| 07/22/2004 | WO2004060052A2 Transgenic mice expressing human cd20 and/or cd16 |
| 07/22/2004 | WO2004046729A3 Bodily fluid markers of tissue hypoxia |
| 07/22/2004 | WO2004046695A3 Method and system for processing and measuring microparticles |
| 07/22/2004 | WO2004046382A3 Product and method |
| 07/22/2004 | WO2004044168A8 Genetically encoded fluorescent reporters of kinase, methyltransferase, and acetyl-transferase activities |
| 07/22/2004 | WO2004044116B1 Anaerobic fermentation method and apparatus |
| 07/22/2004 | WO2004043395A9 Methods and compositions for treating neurological disorders |
| 07/22/2004 | WO2004041202A3 Analysis of pharmaceutical solubility and stability |
| 07/22/2004 | WO2004040398A9 Use of a computer to design a molecule |
| 07/22/2004 | WO2004040259A3 Screening, quantitation and identification of active ingredients in natural products |
| 07/22/2004 | WO2004036175B1 Apparatus and process for sensing fluoro species in semiconductor processing systems |
| 07/22/2004 | WO2004031367A3 Uses of human zven proteins and polynucleotides |
| 07/22/2004 | WO2004029617A3 Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a) |
| 07/22/2004 | WO2004029229A3 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 07/22/2004 | WO2004028554A3 Skrp, astray, string, vacm associated with metabolic control |
| 07/22/2004 | WO2004024884A3 Syts as modifiers of the p21 pathway and methods of use |
| 07/22/2004 | WO2004023143A8 Analytical platform and identification method |
| 07/22/2004 | WO2004021977A3 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
| 07/22/2004 | WO2004021146A3 Systems and methods for sorting protein sequences and structures for visualization |
| 07/22/2004 | WO2004020654A3 Solid phase based nucleic acid assays combining high affinity and high specificity |
| 07/22/2004 | WO2004018991A3 Programmable multiplexed active biologic array |
| 07/22/2004 | WO2004015391A9 Mass spectrometry-based identification of proteins |
| 07/22/2004 | WO2004014936A3 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 07/22/2004 | WO2004010102A3 Impedance based apparatuses and methods for analyzing cells and particles |
| 07/22/2004 | WO2004007547A3 Truncated tau proteins |
| 07/22/2004 | WO2004005529A3 GEF-H1b: BIOMARKERS, COMPLEXES, ASSAYS AND THERAPEUTIC USES THEREOF |
| 07/22/2004 | WO2004001377A3 Improved methods for performing differential capture proteomics |
| 07/22/2004 | WO2003104762A3 Protein micro-arrays and multi-layered affinity interaction detection |
| 07/22/2004 | WO2003104752A3 Water cut rate of change analytic method |
| 07/22/2004 | WO2003098661A3 Chemical and biological hazard sensor system and methods thereof |
| 07/22/2004 | WO2003095973A3 Nanoparticle probes with raman spectroscopic fingerprints for analyte detection |
| 07/22/2004 | WO2003094965A3 Modulation of neural stem cells with s1p or lpa receptor agonists |
| 07/22/2004 | WO2003081202A3 Bioconjugate-nanoparticle probes |
| 07/22/2004 | WO2003077853A9 Immortal porcine cells |
| 07/22/2004 | WO2003073350A8 Method and analytical system for identifying targets in a signaling network |
| 07/22/2004 | WO2003072710A3 Protein biomarkers that distinguish prostate cancer from non-malignant cells |
| 07/22/2004 | WO2003068167A3 Novel treatment for pathologies associated with oxidative damage |
| 07/22/2004 | WO2003061596A3 Methods and reagents for generating chimeric serum peptide carri ers |
| 07/22/2004 | WO2003059148A3 Gene expression profiles in stomach cancer |
| 07/22/2004 | WO2003056301A3 A novel screening method for molecular antagonist using flow-cytometry |
| 07/22/2004 | WO2003053215A3 Diagnosis prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling |
| 07/22/2004 | WO2003052078A3 Insect g protein-coupled receptor genes and uses thereof |
| 07/22/2004 | WO2003045310A9 Digital assay |
| 07/22/2004 | WO2003044511A3 Construction and use of micro-electrode arrays |
| 07/22/2004 | WO2003038114A3 Methods and compositions for the diagnosis and treatment of cellular proliferation disorders using 86604 |
| 07/22/2004 | WO2003031463A3 14081, a human trypsin-like serine protease family member and uses therefor |
| 07/22/2004 | WO2003024302A3 Detection and treatment of cancers of breast |
| 07/22/2004 | WO2003020118A3 Diagnosis and treatment of vascular disease |
| 07/22/2004 | WO2003014299A3 SPHKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/22/2004 | WO2003012395A3 Early detection of mycobacterial disease using peptides |
| 07/22/2004 | WO2003010506A3 Combined electronic-and photonic-based hybridation assay |
| 07/22/2004 | WO2003010326A3 Parallel, antiparallel, homologous or complementary binding of nucleic acids |
| 07/22/2004 | WO2003004623A3 Human secreted proteins |
| 07/22/2004 | WO2003002718A3 Identification and characterization of multiple splice variants of the mu opioid receptor gene |
| 07/22/2004 | WO2002102232A3 A novel signaling pathway for the production of inflammatory pain and neuropathy |
| 07/22/2004 | WO2002099048A3 LIMKs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 07/22/2004 | US20040143865 Transgenic fish models for identifying inhibitors of neovascularization; antitumor/antiproliferative agents; wound healing agents |
| 07/22/2004 | US20040143864 Chimeric gene constructs for generation of fluorescent transgenic ornamental fish |
| 07/22/2004 | US20040143855 Using two domain potassium transport protein to identify modulators of wakefulness; drug screening and potassium channel modulators; sleep disorders |
| 07/22/2004 | US20040143854 Using inducible vectors to transform cells and propagate organism for use as drug screening tools; phenotyping |
| 07/22/2004 | US20040143461 Generating, viewing, interpreting, and utilizing a quantitative database of metabolites |
| 07/22/2004 | US20040143402 System and method for scoring peptide matches |
| 07/22/2004 | US20040143401 identifying the biological mechanisms affected by a selected gene by comparing the response to a perturbance of a 1st reference cell to the response of a 2nd cell in which the selected gene is altered |
| 07/22/2004 | US20040143399 ANOVA method for data analysis |
| 07/22/2004 | US20040143174 System and method for in vitro bleeding time testing |
| 07/22/2004 | US20040143109 Nucleotide sequences for diagnosing periodontal diseases |
| 07/22/2004 | US20040143105 Purified heat shock protein complexes |
| 07/22/2004 | US20040143102 Ligand polypeptide for identifying modulators for treatment of nervous system disorders, schizophrenia and arthritis |
| 07/22/2004 | US20040142888 Modulators of RabGGT and methods of use thereof |
| 07/22/2004 | US20040142886 use of vascular endothelial growth factor to enhance smooth muscle cell proliferation and to treat diseases associated with reduced smooth muscle cell proliferation |
| 07/22/2004 | US20040142871 Osteoporosis treatment |
| 07/22/2004 | US20040142863 modified aggrecanases, nucleotides encoding such enzymes, and processes for producing these enzymes with improved stability; treatment of osteoarthritis |
| 07/22/2004 | US20040142495 for change in the status of a packaged material (foods); generally includes a facestock film having first and second surfaces, an adhesive layer and a detecting system adjacent to the facestock film; can be in vapor and/or liquid form |
| 07/22/2004 | US20040142494 for specifically binding particulates such as cells, especially bacterial cells or hematopoietic cells and a means for detecting the particulates specifically bound to a platform |
| 07/22/2004 | US20040142493 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 07/22/2004 | US20040142492 Using erythrocytic antigens to diagnose disease; in vitro detection of thrombotic and autoimmune disorders |
| 07/22/2004 | US20040142491 Raised microarrays for use in discovering useful drug candidates; drug screening and development; high throughput assay; proteomic |
| 07/22/2004 | US20040142490 Using enhanced presence of estrogen related receptor gamma in mammary gland tissue to identify patients/individuals which tomaxifin may benifit; cancer diagnosis and treatment; antiproliferative agents |
| 07/22/2004 | US20040142486 Systems and methods for sorting samples |
| 07/22/2004 | US20040142483 Calibration data entry system for a test instrument |
| 07/22/2004 | US20040142453 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis |
| 07/22/2004 | US20040142431 Nucleotide sequences comprising restriction fragment length polymorphisms coding polypeptide with antiproliferative, antiviral and antiparasitic effects |
| 07/22/2004 | US20040142427 Nucleotide sequences coding lyase for use as tool in identifying treatments which prevent or inhibit tumor cell metastasis, inflammation and autoimmunity |
| 07/22/2004 | US20040142421 Pacemake ion channel proteins and uses thereof |
| 07/22/2004 | US20040142410 Using fluorescence polarization to identify glucuronosyltransferases involved in xenobiotic transformations; enzyme assays |
| 07/22/2004 | US20040142406 Method of colorimetry and reagent for use therein |
| 07/22/2004 | US20040142405 Method of detecting drug resistance |
| 07/22/2004 | US20040142403 Using minimally invasive or noninvasive diagnostic means to determine/detect defects in glucose tolerance; blood sugar profile |